If you’ve tried one antidepressant after another and still don’t feel like yourself, you’re not “beyond repair.” Treatment-resistant depression is a recognized clinical reality, not a reflection of how hard you’ve tried or how “treatable” you are as a person.
It affects a lot of people living with major depression, and it’s one of the most researched areas in psychiatry today, precisely because so many people need options beyond the first or second medication they’re handed.
The good news, if it can be called that, is that “resistant” doesn’t mean “untreatable.” It means the standard first steps haven’t worked yet, and there is a wider range of evidence-based options available now than there was even a few years ago.
What Treatment-Resistant Depression Means
Clinically, treatment-resistant depression (TRD) generally refers to major depressive disorder that hasn’t responded adequately to at least two different antidepressant medications, taken at proper doses for a sufficient length of time.
Think of it more as a widely used clinical label and a spectrum, as opposed to a single universally agreed-upon diagnosis. Still, the pattern it describes is well recognized—continuing to struggle with depression despite good-faith efforts with standard treatment.
And it’s more common than many people realize. Research estimates suggest that roughly a third of people with major depressive disorder don’t respond adequately to standard antidepressant treatment, and TRD is understood to affect millions of adults at any given time.
If this describes you, you should know that you are part of a large, well-documented group, not an outlier and not a failure of treatment.
Living with TRD often looks like:
- Trying multiple antidepressants, sometimes for months at a time, with only partial or no relief.
- Feeling like you’ve “done everything right” (therapy, medication, lifestyle changes) without real improvement.
- Cycling through side effects from different medications without getting the payoff of feeling better.
- Wondering whether something is uniquely wrong with you without realizing this as a recognized clinical pattern.
- Losing hope that any treatment will really work, which can itself become part of the weight you’re carrying.
Why Standard Antidepressants Don’t Work for Everyone
Most first-line antidepressants like SSRIs and SNRIs work by adjusting serotonin and norepinephrine levels in the brain. For many people, this approach works well.
But depression isn’t a single, uniform condition, and increasingly, research points to multiple biological pathways that can contribute to it, including glutamate signaling, inflammation, and stress-hormone regulation, none of which standard antidepressants directly target.
This is part of why response to any single medication varies so much from person to person, and why finding the right treatment can sometimes mean looking at approaches that work through a completely different mechanism than the medications you may have already tried.
The Main Treatment Options for TRD
The treatments below don’t need to be understood as a ladder you climb from “least serious” to “most serious.” Each works through a different mechanism, fits different circumstances, and comes with its own trade-offs in speed, commitment, and access.
Some people find relief in the first option they try beyond standard medication; others need to combine approaches, or move through more than one before finding the right fit.
What follows is an overview of the main paths available today, so you can go into a conversation with a clinician already understanding the landscape.
Ketamine and Esketamine
Ketamine and its derivative esketamine represent one of the more significant developments in TRD treatment in recent decades, mainly because they work through a different biological pathway than traditional antidepressants. They target the brain’s glutamate system instead of serotonin.
This is also why they tend to act far faster. While SSRIs typically take four to six weeks to show effect, ketamine and esketamine can ease depressive symptoms within hours to days.
- Esketamine (Spravato): FDA-approved specifically for treatment-resistant depression, it’s delivered as a nasal spray in a monitored clinical setting alongside an oral antidepressant. It also carries FDA approval for depression with suicidal ideation and is more likely to be covered by insurance given its approved status.
- Ketamine: The original compound, administered intramuscularly, intravenously, or sublingually, is used off-label for depression. It has a longer clinical track record than esketamine and is often given as a series of infusions, typically administered by a clinic offering ketamine-assisted treatment.
Both approaches require ongoing treatment to maintain benefits. This isn’t a one-and-done intervention, but rather a tool that, for many people, opens a window where greater improvement becomes possible, especially when paired with therapy.
Transcranial Magnetic Stimulation (TMS)
TMS is a non-invasive treatment that uses magnetic pulses to stimulate the prefrontal cortex, an area of the brain closely tied to mood regulation. It’s typically delivered as daily sessions over several weeks, doesn’t require anesthesia, and has a favorable safety profile. It isn’t appropriate for everyone, though, and people with certain implanted metal devices or a history of seizures need individualized evaluation. But for many, it offers a significantly different option from medication alone.
Electroconvulsive Therapy (ECT)
ECT remains one of the most effective treatments in psychiatry for severe or treatment-resistant depression, particularly when rapid improvement is needed, such as in cases involving psychotic features or acute suicidality.
It also carries more scientific evidence behind it than almost any other psychiatric treatment, having been in continuous clinical use for nearly 90 years and refined substantially since its introduction in the late 1930s.
Despite its outdated reputation in popular culture, modern ECT is performed under anesthesia and is closely monitored. It does typically require more logistical commitment than other options and can involve short-term memory effects, which is something you should discuss openly with your provider.
Augmentation and Combination Strategies
Sometimes the answer isn’t switching treatments, but adding to what’s already partially working. This might mean combining an existing antidepressant with a second medication, adding structured psychotherapy, or in some cases, combining approaches like ketamine with TMS or with talk therapy. Research increasingly points to combination approaches as valuable for durability of results, particularly using ketamine’s window of rapid relief to make other therapeutic work more accessible.
Psychotherapy Is a Steady Companion to Every Other Option
Whatever medical treatment path you pursue, evidence-based psychotherapy (particularly cognitive behavioral therapy and other structured approaches) continues to play an important role in TRD treatment, both alongside medication and interventions like ketamine. Access and consistency can be real barriers here, which is part of why so many combination approaches exist—to give people more than one entry point into feeling better.
Main Treatment Options for TRD, Compared
Here’s how all these treatments compare when stacked up. Just keep in mind that this table is meant as a starting point for conversation, not a substitute for one. Which option makes sense for you is something you will have to decide with your healthcare provider.
| Esketamine (Spravato) | Ketamine | TMS | ECT | Psychotherapy | |
| How it works | Targets the glutamate system (nasal spray with an oral antidepressant) | Targets the glutamate system (IM/IV/sublingual) | Magnetic pulses stimulate the prefrontal cortex | Induces a controlled seizure under anesthesia to reset brain activity | Structured talk therapy addressing thought patterns and coping skills |
| Onset of relief | Hours to days | Hours to days | Gradual, over weeks | Often rapid, within days to a couple of weeks | Gradual, typically over weeks to months |
| Typical commitment | Twice weekly for 4 weeks, once weekly for 4 weeks, then maintenance sessions as needed | Typically six sessions (two to three weeks) with booster sessions if needed | Daily sessions, typically over several weeks | Multiple sessions per week over several weeks | Weekly sessions, often ongoing alongside other treatments |
| FDA status | Approved for TRD and for depression with suicidal ideation | Off-label use for depression | Cleared for TRD | Cleared, with nearly 90 years of clinical use and evidence | Not applicable (not a medication) |
How to Think About Choosing a Path to Treat Depression
As we said, there’s no single “correct” order to try these options in, and the right fit depends on your history, your symptoms’ severity, your logistics, and what you’ve already tried. Some general patterns that clinicians consider:
- How many medications you’ve already tried without success, and at what doses.
- Whether you’re dealing with an acute safety concern, such as suicidal thinking, which may point toward faster-acting options.
- How much time and logistical flexibility you have. Some treatments require daily visits for weeks, while others require a shorter, more concentrated course.
- Whether previous side effects or health conditions rule certain options in or out.
- What you personally feel ready for, both practically and emotionally.
None of this needs to be figured out alone. A clinician who understands your full treatment history is best positioned to help you weigh these options with clarity, including the trade-offs of each.
You’re Not Out of Options
If you’ve reached the point of searching for “treatment-resistant depression treatment options” because nothing so far has worked, you should know that how you feel is a well-recognized, well-studied condition, and having gotten this far without relief says nothing about you or your capacity to get better.
It just says that the first approaches weren’t the right fit, and that’s something that happens more often than most people realize, which is exactly why so many other paths now exist.
We’re Here When You’re Ready to Talk
You don’t need to have already decided on a treatment, or even be sure ketamine is right for you, to reach out. Sometimes the hardest part is just starting the conversation, which is why you get a free consultation. Our team at Kadelyx is here to listen to what you’ve already tried, answer your questions honestly, and help you understand whether ketamine-assisted treatment could be a next step without any pressure or obligation.
